We are an early-stage venture capital fund investing in highly technological B2B software solutions, from Seed to Series A all across Europe, North America, and LatAm.
We invest in technology with the power to drive a disruptive change in the world.
Specialized in biotechnology, the result of the collaboration between the Science & Life Foundation and Venturance Alternative Assets , focused on promoting the growth of emerging biotechnology companies.